Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00420355 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
A Phase 4 study, sponsored by University of Oklahoma.
- Terminated
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT00420355 is a Phase 4 study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 19 participants.
The verdict
NCT00420355, a Phase 4 study, was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
The objective of this study is to determine the pharmacokinetics of lopinavir, ritonavir, and atazanavir when lopinavir/ritonavir and atazanavir are used in combination.
Interventions
- DRUG atazanavir
- DRUG lopinavir/ritonavir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00420355
The ClinicalTrials.gov registry entry for NCT00420355 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which atazanavir is the first listed.
NCT00420355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00420355 about?
NCT00420355 is a clinical study titled "Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients". The objective of this study is to determine the pharmacokinetics of lopinavir, ritonavir, and atazanavir when lopinavir/ritonavir and atazanavir are used in combination.
What is the current status of trial NCT00420355?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2007-04. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00420355?
The interventions under investigation include: atazanavir (DRUG), lopinavir/ritonavir (DRUG).
Who is sponsoring clinical trial NCT00420355?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.